Acidic fibroblast growth factor (aFGF) injection stimulates cartilage enlargement and inhibits cartilage gene expression in rat fracture healing.
The effect of the administration of acidic fibroblast growth factor (aFGF) on normal fracture healing was examined in a rat fracture model. One microgram of aFGF was injected into the fracture site between the first and the ninth day after fracture either every other day or every day. aFGF-injected calluses were significantly larger than control calluses, although this does not imply an increased mechanical strength of the callus. Histology showed a marked increase in the size of the cartilaginous soft callus. Total DNA and collagen content in the cartilaginous portion of the aFGF-injected calluses were greater than those of controls, although the collagen content/DNA content ratio was not different between the aFGF-injected and control calluses. Fracture calluses injected with aFGF remained larger than controls until 4 weeks after fracture. The enlarged cartilaginous portion of the aFGF-injected calluses seen at 10 days after fracture was replaced by trabecular bone at 3 and 4 weeks. Northern blot analysis of total cellular RNA extracted separately from the cartilaginous soft callus and the bony hard callus showed decreased expression of type II procollagen and proteoglycan core protein mRNA in the aFGF-injected calluses when compared with controls. A slight decrease in types I and III procollagen mRNA expression was also observed. We concluded that aFGF injections induced cartilage enlargement and decreased mRNA expression for type II procollagen and proteoglycan core protein.
Jingushi
S
S
Orthopaedic Research Unit, NIAMS, NIH, Bethesda, MD 20892.
Heydemann
A
A
Kana
S K
SK
Macey
L R
LR
Bolander
M E
ME
D000818:Animals; D002146:Bony Callus / Q000254:growth & development*; D002356:Cartilage / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D004195:Disease Models, Animal; D005109:Extracellular Matrix / Q000032:analysis / Q000378:metabolism; D005346:Fibroblast Growth Factors / Q000008:administration & dosage / Q000494:pharmacology* / Q000502:physiology; D050723:Fractures, Bone / Q000473:pathology / Q000503:physiopathology*; D015870:Gene Expression / Q000187:drug effects* / Q000502:physiology; D007267:Injections; D008297:Male; D011506:Proteins / Q000032:analysis / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D014945:Wound Healing / Q000187:drug effects / Q000502:physiology
D011506:Proteins; D012333:RNA, Messenger; D005346:Fibroblast Growth Factors